X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

BLPH

Closed

Bellerophon Therapeutics Inc

0.012
0.000 (0.00%)
Last Update: 18 Dec 2024 20:51:00
Yesterday: 0.012
Day's Range: 0.012 - 0.0126
Send
When Written:
 
7.89
Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company that is focused on developing innovative therapies for cardiopulmonary diseases. The company's lead product candidate, INOpulse, is a proprietary pulsatile nitric oxide delivery system that is designed to improve oxygenation and reduce pulmonary hypertension in patients with various cardiopulmonary diseases. INOpulse is currently being evaluated in multiple clinical trials for the treatment of pulmonary arterial hypertension, pulmonary hypertension associated with interstitial lung disease, and pulmonary hypertension associated with chronic obstructive pulmonary disease. Bellerophon Therapeutics Inc is headquartered in Warren, New Jersey and was founded in 2009.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X